Global

Global Women’s Digital Health Market Outlook, 2025–2032

Global Women’s Digital Health Market Forecast 2025–2032 Added to ResearchAndMarkets.com ResearchAndMarkets.com has announced the addition of its latest industry report, “Women’s Digital Health Market – Global Forecast 2025–2032,” offering an in-depth analysis of one of the fastest-growing segments within the…

Read MoreGlobal Women’s Digital Health Market Outlook, 2025–2032
Spinol

Spinol Medical’s OctaSeal™ Enters FDA Review with 5-Year Clinical Data

Spinol Medical™ Advances OctaSeal™ Annular Closure System Into FDA Review, Introducing a Minimally Invasive Intradiscal Solution Supported by Five-Year Clinical Data Spinol Medical™ today announced that its OctaSeal™ Annular Closure System has advanced into formal review by the U.S. Food…

Read MoreSpinol Medical’s OctaSeal™ Enters FDA Review with 5-Year Clinical Data
HealthStream

HealthStream Adds Nation’s Largest Caregiver Network with Mission Care Collective Deal

HealthStream Expands Workforce Ecosystem with Acquisition of MissionCare Collective, Strengthening Caregiver Career Networks Nationwide HealthStream, a leading healthcare technology company specializing in workforce development solutions, today announced the acquisition of MissionCare Collective LLC (“MissionCare”), a healthcare workforce organization recognized for…

Read MoreHealthStream Adds Nation’s Largest Caregiver Network with Mission Care Collective Deal
GenSci

GenSci and RTW Partner on GS-098 for Graves’ and Thyroid Eye Disease

GenSci, RTW Investments, and Yarrow Bioscience Enter Strategic Global Partnership to Advance First-in-Class Anti-TSHR Antibody for Graves’ Disease and Thyroid Eye Disease SHANGHAI & NEW YORK Shanghai Scizeng Medical Technology Co LTD, a subsidiary of Changchun GeneScience Pharmaceutical (“GenSci”), together…

Read MoreGenSci and RTW Partner on GS-098 for Graves’ and Thyroid Eye Disease
Natera

Natera and MEDSIR Announce Collaboration on MiRaDoR Breast Cancer Study

Natera and MEDSIR Partner on MiRaDoR Trial to Advance Genome-Guided Treatment Strategies in HR+/HER2- Breast Cancer Natera a global leader in cell-free DNA (cfDNA) testing and precision medicine, and MEDSIR (Medica Scientia Innovation Research), an international clinical research organization specializing…

Read MoreNatera and MEDSIR Announce Collaboration on MiRaDoR Breast Cancer Study
FDA

FDA Clears NUZOLVENCE First Single-Dose Oral Treatment for Gonorrhea

Innoviva Specialty Therapeutics, a subsidiary of Innoviva, today announced that the U.S. Food and Drug Administration (FDA) has approved NUZOLVENCE (zoliflodacin) for oral suspension, a first-in-class, single-dose oral antibiotic for the treatment of uncomplicated urogenital gonorrhea in adults and adolescents…

Read MoreFDA Clears NUZOLVENCE First Single-Dose Oral Treatment for Gonorrhea
Elevance

Elevance Health Reflects on the Evolving Responsibilities of Health Plans

Elevance Health Reflects On The Evolving Role Of Health Plans By simplifying the healthcare experience, strengthening care coordination, and applying data-driven insights, Elevance Health and its affiliated health plans are redefining how members engage with healthcare helping individuals and families…

Read MoreElevance Health Reflects on the Evolving Responsibilities of Health Plans
SBC

SBC Medical Group Holdings Completes Tender Offer for Waqoo, Inc. Shares

SBC Medical Group Holdings Completes Strategic Tender Offer for Waqoo, Strengthening R&D and Regenerative Medicine Capabilities SBC Medical Group Holdings Incorporated (“SBC Medical” or the “Company”), a global provider of integrated consulting, operational management, and strategic support services for medical…

Read MoreSBC Medical Group Holdings Completes Tender Offer for Waqoo, Inc. Shares